Piramal Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Sep '26 | ||||
|---|---|---|---|---|---|
Total Qtr Revenue cr | 2,652.99 | ||||
| Other Income Qtr Cr | 35.93 | ||||
| Operating Revenues Qtr | 2,617.06 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 2,268.32 | ||||
Operating Profit Qtr | 348.74 | ||||
EBITDA Qtr Cr | 384.67 | ||||
Depreciation Qtr | 233.15 | ||||
Net Profit Qtr | 5.58 | ||||
Basic EPS Qtr | 0.04 | ||||